The lack of information from GTHP is getting tiresome. Looking forward to the conference call. I guess we will have to wait until next week to find out about the offering. The stock looks weak as the market desperately needs guidance on the offering.
I am very bullish on GTHP right now. I think we are on the brink of significant changes to the capital structure that are long term positive for GTHP. In essence, the offering will delete the BK option and enables us to wait for the FDA. Obviously I am expecting FDA approval in early 2015 for Luviva. However, I was hoping for the offering to be done by now. Based on the timing of the PR I am guessing outstanding issues are getting resolved and Nov 14th seems a logical time to complete the offering. My hope is at least $6mm @ 30 cents.
Filing the 10Q is a requirement for the S1 to become effective. Obviously, we are close to completion but the pricing is disappointing at best. I believe the whole process was handle very poorly.
Not a typo. I was told it is a legal requirement from the Auditor. Translation, I do not think they are thinking about another offering in 10-12 months.
My thoughts exactly.... My last post at investor village sounds similar to yours. I pasted mine below....
I am really puzzled by how much this board loves Mr. Cartwright. I had several conversations with Mr. Cartwright during the last 2 months. He is an extremely nice and open person. However, in my modest opinion, his execution is poor at best. In a matter of fact, it was Mr. Cartwright that told me to expect completion of the offering by the end of the month (October). He communicated the same to others in this board. When I spoke with him October 30th, he said he was hoping for completion of the offering in early November and felt confident of completion by November 14th. However, November 14th the offering was not completed. Instead we got another update. This time we where told at the beginning of the conference call to expect completion within days. As of November 21 (one week later) we are still waiting. Do you see the pattern? Don't you think he has over promised and under delivered again?
More importantly, GTHP stock price has plunged this year. As an investor stock performance is a key driver to determine how effective the mgmt has performed. I will keep quiet about Mr. Cartwright going forward since everyone in this board has a man crush on the guy. Maybe if the stock moves below 20 cents your support for Mr. Cartwright will increase.
Let's hope for completion of the offering next week and that we finally start seeing large orders next month. I keep hoping and WE OBVIOUSLY WANT THE SAME OUTCOME. Best luck to you and truly hope Mr. Cartwright shows everyone in this board how wrong I am about him. That would be a very nice change.
Lilith/jennifer/punta/GTPH 10 bagger..... I agree with you on you last comment. I thought a partnership instead of a offering was a better path. My only hope is that insiders are using this offering to accumulate shares before a run up. If they complete the offering will like to know which insiders bought and how much.
Now that the offering is completed and insiders probably loaded at 22.5 cents will we start getting good news flow? Are we finally going to hear from mgmt regarding accelerating sales in 2015? Tide is finally turning it seems. I wish I was starting my position here. Time to average down my cost basis.
Good clinical studies results from Nigeria and Turkey. I believe the next step to move us higher is insider buying and a large order prior to year end. I would be surprised if insiders did not use the opportunity to buy additional shares at 22.5 cents. The offering was closed yesterday so we should find soon if insiders participated in the offering. In addition, during the last conference call Mr. Cartwright hinted about the possibility of getting Banglasdesh prior to year-end. News of insiders buying and large order could set us up for a nice rally ahead of FDA news (panel review date). An update from FDA is expected @ the end of January.
I could not agree more. I am betting / hoping we start seeing large orders sooner rather than later. Maybe I am just too jaded but now that the offering is completed I expect news flow to improve dramatically. We are due anyhow :-).... So Bangladesh next week!
Offering investors are shorting against the common and keeping the warrants. No risk all upside. Tonoos was discussing this possibility for the last several days as well as discussing TA information. Seanoise is very knowledge of FDA "mechanics" and has done a ton of research on GTHP. The investor village board is by far better than this board IMHO. Anyhow, best luck to you with GTHP. Let's hope for Bangladesh offer announcement next week.
New owners from the offering continue selling / shorting their common at 22.5 cents or above making it impossible for the stock to move forward. Why not? Sale the common and keep the warrants. We are probably having some tax selling as well. Waiting for a large order to change the game. I do not expect any FDA news until next month. Maybe Gene can come thru with ORDERS. "Ideally" sooner rather than later.
We should have enough cash until the end of Q2 2015. We expect a panel review announcement by late January. As a result the panel review is expected by March/April. So we have enough cash to take us to FDA decision. However, we need to see large orders sooner rather than later.